Financhill
Sell
38

FIS Quote, Financials, Valuation and Earnings

Last price:
$49.14
Seasonality move :
6.27%
Day range:
$48.50 - $49.63
52-week range:
$46.16 - $82.74
Dividend yield:
3.26%
P/E ratio:
154.69x
P/S ratio:
2.49x
P/B ratio:
1.84x
Volume:
3.4M
Avg. volume:
5.1M
1-year change:
-29.66%
Market cap:
$25.4B
Revenue:
$10.1B
EPS (TTM):
$0.32
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $12.6B $13.9B $9.7B $9.8B $10.1B
Revenue Growth (YoY) 21.48% 10.56% -29.96% 1.15% 3.01%
 
Cost of Revenues $8.3B $8.7B $6.2B $6.2B $6.3B
Gross Profit $4.2B $5.2B $3.5B $3.7B $3.8B
Gross Profit Margin 33.49% 37.44% 36.04% 37.19% 37.56%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.5B $3.9B $2.2B $2.1B $2.2B
Other Inc / (Exp) -$88M -$303M -$100M -$277M -$214M
Operating Expenses $2.7B $3.1B $1.6B $1.6B $1.4B
Operating Income $1.5B $2.1B $1.9B $2B $2.4B
 
Net Interest Expenses $339M $216M $298M $713M $351M
EBT. Incl. Unusual Items $266M $789M $941M $662M $1.3B
Earnings of Discontinued Ops. -- -- -$17.3B -$7.2B $663M
Income Tax Expense $96M $371M $325M $157M $362M
Net Income to Company $164M $424M -$16.7B $505M $790M
 
Minority Interest in Earnings $6M $7M $12M $7M $3M
Net Income to Common Excl Extra Items $164M $424M $616M $505M $790M
 
Basic EPS (Cont. Ops) $0.26 $0.68 -$27.68 -$11.26 $1.42
Diluted EPS (Cont. Ops) $0.25 $0.67 -$27.68 -$11.26 $1.42
Weighted Average Basic Share $619M $616M $604M $591M $553M
Weighted Average Diluted Share $627M $621M $604M $591M $555M
 
EBITDA $5.3B $6.1B $3.5B $3.6B $4.1B
EBIT $1.5B $2.1B $1.9B $2B $2.4B
 
Revenue (Reported) $12.6B $13.9B $9.7B $9.8B $10.1B
Operating Income (Reported) $1.5B $2.1B $1.9B $2B $2.4B
Operating Income (Adjusted) $1.5B $2.1B $1.9B $2B $2.4B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $3.5B $2.4B $2.5B $2.6B $2.7B
Revenue Growth (YoY) 9.7% -31.14% 3.19% 3.13% 5.72%
 
Cost of Revenues $2.2B $1.5B $1.5B $1.6B $1.7B
Gross Profit $1.3B $881M $961M $977M $1B
Gross Profit Margin 37.9% 36.48% 38.56% 38.02% 37.84%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $989M $480M $484M $521M $584M
Other Inc / (Exp) -$92M $1M $4M -$40M --
Operating Expenses $802M $357M $371M $348M $372M
Operating Income $527M $524M $590M $629M $656M
 
Net Interest Expenses $46M $78M $162M $64M $90M
EBT. Incl. Unusual Items $202M $324M $319M $388M $375M
Earnings of Discontinued Ops. -- $31M -$709M -$22M --
Income Tax Expense $41M $102M $70M $108M $87M
Net Income to Company $169M $254M -$446M $202M $266M
 
Minority Interest in Earnings $3M $4M $1M $1M $1M
Net Income to Common Excl Extra Items $161M $222M $249M $247M $265M
 
Basic EPS (Cont. Ops) $0.26 $0.41 -$0.78 $0.46 $0.51
Diluted EPS (Cont. Ops) $0.26 $0.41 -$0.78 $0.45 $0.50
Weighted Average Basic Share $613M $605M $592M $545M $521M
Weighted Average Diluted Share $619M $607M $592M $548M $523M
 
EBITDA $1.6B $1.5B $1B $1.1B $1.1B
EBIT $527M $524M $590M $629M $656M
 
Revenue (Reported) $3.5B $2.4B $2.5B $2.6B $2.7B
Operating Income (Reported) $527M $524M $590M $629M $656M
Operating Income (Adjusted) $527M $524M $590M $629M $656M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $13.5B $13.3B $9.8B $10B $10.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $8.5B $8.3B $6.2B $6.2B $6.6B
Gross Profit $5B $5B $3.7B $3.8B $3.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.9B $3.6B $2.1B $2.2B $2.2B
Other Inc / (Exp) -$380M -$38M -$177M -$438M --
Operating Expenses $2.9B $3.8B $1.6B $1.5B $1.4B
Operating Income $2.1B $1.2B $2B $2.3B $2.4B
 
Net Interest Expenses $250M $214M $576M $342M $347M
EBT. Incl. Unusual Items $475M $1.3B $784M $887M $1.2B
Earnings of Discontinued Ops. -- $31M -$24.8B $874M -$23M
Income Tax Expense $248M $358M $243M $230M $324M
Net Income to Company $236M $946M -$24.3B $8.6B -$507M
 
Minority Interest in Earnings $6M $8M $5M $4M $4M
Net Income to Common Excl Extra Items $235M $914M $541M $548M $179M
 
Basic EPS (Cont. Ops) $0.37 $1.54 -$40.97 $1.31 $0.32
Diluted EPS (Cont. Ops) $0.37 $1.53 -$40.97 $1.30 $0.32
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $6B $5.2B $3.8B $4B $4.3B
EBIT $2.1B $1.2B $2B $2.3B $2.4B
 
Revenue (Reported) $13.5B $13.3B $9.8B $10B $10.5B
Operating Income (Reported) $2.1B $1.2B $2B $2.3B $2.4B
Operating Income (Adjusted) $2.1B $1.2B $2B $2.3B $2.4B
Period Ending 2022-09-30 2023-09-30 2024-09-30 2025-09-30 2026-09-30
Revenue $9.6B $7.3B $7.5B $7.9B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6B $4.6B $4.7B $5B --
Gross Profit $3.6B $2.7B $2.8B $2.9B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.6B $1.6B $1.7B $1.7B --
Other Inc / (Exp) $5M -$110M -$243M -$198M --
Operating Expenses $3B $1.2B $1.1B $1.1B --
Operating Income $578M $1.5B $1.7B $1.7B --
 
Net Interest Expenses $168M $464M $184M $280M --
EBT. Incl. Unusual Items $856M $566M $809M $744M --
Earnings of Discontinued Ops. $31M -$7.3B $686M -- --
Income Tax Expense $233M $136M $215M $178M --
Net Income to Company $655M -$6.9B $1.1B -$126M --
 
Minority Interest in Earnings $8M $2M $3M $3M --
Net Income to Common Excl Extra Items $623M $430M $485M -$126M --
 
Basic EPS (Cont. Ops) $1.06 -$11.68 $0.88 -$0.24 --
Diluted EPS (Cont. Ops) $1.06 -$11.68 $0.88 -$0.25 --
Weighted Average Basic Share $1.8B $1.8B $1.7B $1.6B --
Weighted Average Diluted Share $1.8B $1.8B $1.7B $1.6B --
 
EBITDA $3.5B $2.8B $3B $3.1B --
EBIT $578M $1.5B $1.7B $1.7B --
 
Revenue (Reported) $9.6B $7.3B $7.5B $7.9B --
Operating Income (Reported) $578M $1.5B $1.7B $1.7B --
Operating Income (Adjusted) $578M $1.5B $1.7B $1.7B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $2B $2B $456M $440M $834M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3.5B $3.8B $1.8B $1.7B $2B
Inventory -- -- -- -- --
Prepaid Expenses -- $530M $439M $463M $353M
Other Current Assets $4.3B $2.8B $509M $641M $638M
Total Current Assets $9.9B $10.7B $12.8B $13.7B $5.2B
 
Property Plant And Equipment $1.4B $1.4B $960M $909M $876M
Long-Term Investments $137M $358M $611M $835M $4.8B
Goodwill $53.3B $53.3B $16.8B $17B $17.3B
Other Intangibles $17.3B $14.8B $4.5B $3.9B $3.8B
Other Long-Term Assets $959M $977M $26.6B $17.4B $441M
Total Assets $83.8B $82.9B $63.3B $55B $33.8B
 
Accounts Payable $1.6B $1.8B $623M $110M $239M
Accrued Expenses $518M $456M $474M $1.3B $1.2B
Current Portion Of Long-Term Debt $1.5B $1.7B $2.1B $1.3B $968M
Current Portion Of Capital Lease Obligations $152M $146M $99M $85M $74M
Other Current Liabilities -- -- $7.4B $8.9B $1.1B
Total Current Liabilities $12.4B $14.5B $16.2B $18.2B $6.1B
 
Long-Term Debt $16.4B $15.2B $14.4B $13.1B $9.9B
Capital Leases -- -- -- -- --
Total Liabilities $34.4B $35.4B $35.9B $35.9B $18.1B
 
Common Stock $6M $6M $6M $6M $6M
Other Common Equity Adj $57M $252M -$360M -$260M -$364M
Common Equity $49.3B $47.3B $27.2B $19B $15.7B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $187M $185M $188M $6M $2M
Total Equity $49.5B $47.5B $27.4B $19.1B $15.7B
 
Total Liabilities and Equity $83.8B $82.9B $63.3B $55B $33.8B
Cash and Short Terms $2B $2B $456M $440M $834M
Total Debt $17.7B $16.8B $16.6B $14.5B $10.8B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $1.4B $1.9B $466M $1.3B $571M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3.5B $3.4B $1.7B $1.9B $2.3B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $325M
Other Current Assets $489M $2.9B $546M $621M --
Total Current Assets $10B $10.6B $12.2B $6.1B $4B
 
Property Plant And Equipment $846M $839M $682M $620M $709M
Long-Term Investments $354M $463M $228M $4.3B $4B
Goodwill $52.8B $51B $16.8B $17.1B --
Other Intangibles $15.2B $12.3B $4B $3.6B --
Other Long-Term Assets $1.9B $2.5B $18.5B $1.7B --
Total Assets $81.7B $78.3B $53.2B $34.3B $33B
 
Accounts Payable $2.5B $2.5B $1.5B $220M $257M
Accrued Expenses -- -- -- $1B --
Current Portion Of Long-Term Debt $479M $3B $1.3B $317M --
Current Portion Of Capital Lease Obligations -- -- -- $81M --
Other Current Liabilities -- -- $7.3B $1.3B --
Total Current Liabilities $12.6B $13.7B $16.1B $5.1B $7.5B
 
Long-Term Debt $15.8B $13.5B $12.7B $10.5B $8.9B
Capital Leases -- -- -- -- --
Total Liabilities $34.4B $32.8B $33.7B $17.8B $19.2B
 
Common Stock $6M $6M $6M $6M $6M
Other Common Equity Adj $156M -$392M -$408M -$387M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $188M $187M $7M $2M $3M
Total Equity $47.3B $45.5B $19.5B $16.6B $13.9B
 
Total Liabilities and Equity $81.7B $78.3B $53.2B $34.3B $33B
Cash and Short Terms $1.4B $1.9B $466M $1.3B $571M
Total Debt $16.3B $16.5B $14.1B $10.8B $10.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $164M $424M -$16.7B $505M $790M
Depreciation & Amoritzation $3.7B $4B $3.8B $1.7B $1.7B
Stock-Based Compensation $283M $383M $215M $120M $186M
Change in Accounts Receivable -$89M -$552M -$155M $341M -$178M
Change in Inventories -- -- -- -- --
Cash From Operations $4.4B $4.8B $3.9B $4.3B $2.1B
 
Capital Expenditures $1.1B $1.3B $1.4B $780M $817M
Cash Acquisitions $469M $767M -- $375M $3.7B
Cash From Investing -$914M -$1.8B -$373M -$1.5B $8.1B
 
Dividends Paid (Ex Special Dividend) $868M $961M $1.1B $1.2B $800M
Special Dividend Paid
Long-Term Debt Issued $47.7B $54.1B $75.3B $93.1B $25.4B
Long-Term Debt Repaid -$49.1B -$53.4B -$74.3B -$94.4B -$33.2B
Repurchase of Common Stock $112M $2.1B $1.9B $522M $4B
Other Financing Activities -$731M -$217M -$43M -$183M $37M
Cash From Financing -$2.8B -$2.5B -$2.6B -$3.3B -$12.6B
 
Beginning Cash (CF) $2B $2B $456M $440M $834M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $819M $253M $530M -$399M -$2.5B
Ending Cash (CF) $2.8B $2B $523M $151M -$1.7B
 
Levered Free Cash Flow $3.3B $3.6B $2.5B $3.6B $1.3B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $291M -$17.4B $7.4B -$381M --
Depreciation & Amoritzation $1B $926M $421M $446M --
Stock-Based Compensation $63M $17M $30M $44M --
Change in Accounts Receivable -$323M -$316M $184M -$67M --
Change in Inventories -- -- -- -- --
Cash From Operations $1.1B $1.1B $10.4B -$9M --
 
Capital Expenditures $374M $307M $196M $188M --
Cash Acquisitions $767M -- $202M $471M --
Cash From Investing -$1.2B -$205M -$754M -$704M --
 
Dividends Paid (Ex Special Dividend) $237M $280M $305M $192M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $13.5B $25.3B $28.7B $9.7B --
Long-Term Debt Repaid -$12.8B -$25B -$28.6B -$9B --
Repurchase of Common Stock $1M $548M $506M $1B --
Other Financing Activities -$5M $309M -- -$2M --
Cash From Financing $499M -$683M -$1B -$609M --
 
Beginning Cash (CF) $2B $456M $440M $834M --
Foreign Exchange Rate Adjustment -$191M $319M $139M -$53M --
Additions / Reductions $247M $572M $8.7B -$1.4B --
Ending Cash (CF) $2.1B $1.3B $9.3B -$594M --
 
Levered Free Cash Flow $739M $834M $10.2B -$197M --
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $236M $946M -$24.3B $8.6B -$507M
Depreciation & Amoritzation $3.9B $4B $2.2B $1.7B $1.9B
Stock-Based Compensation $421M $261M $107M $172M $180M
Change in Accounts Receivable -$355M -$162M -$159M $75M $42M
Change in Inventories -- -- -- -- --
Cash From Operations $5.1B $3.9B -$4.9B $12.1B $2.2B
 
Capital Expenditures $1.2B $1.5B $891M $825M $853M
Cash Acquisitions -- $767M $173M $3.4B $2.5B
Cash From Investing -$296M -$1.3B -$975M $8.1B -$3.5B
 
Dividends Paid (Ex Special Dividend) $942M $1.1B $1.2B $913M $832M
Special Dividend Paid
Long-Term Debt Issued $51.1B $63.5B $89.7B $44.4B --
Long-Term Debt Repaid -$52.1B -$62.1B -$90.8B -$52.8B --
Repurchase of Common Stock $2.1B $1.4B $564M $3.5B $2.1B
Other Financing Activities -$721M -$357M $126M $39M --
Cash From Financing -$4.6B -$1.4B -$3B -$13B -$1.4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $201M $205M -$8.6B $7.6B -$2.8B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $3.9B $2.5B -$5.8B $11.3B $1.3B
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Net Income to Stockholders -$16.7B $505M $767M -$126M --
Depreciation & Amoritzation $3.8B $1.7B $1.7B $1.4B --
Stock-Based Compensation $215M $120M $186M $136M --
Change in Accounts Receivable -$155M $341M -$176M $109M --
Change in Inventories -- -- -- -- --
Cash From Operations $3.9B $4.3B $1.8B $2.2B --
 
Capital Expenditures $1.4B $780M $817M $665M --
Cash Acquisitions -- $375M $3.7B $2B --
Cash From Investing -$373M -$1.5B $8.1B -$2.8B --
 
Dividends Paid (Ex Special Dividend) $1.1B $1.2B $800M $640M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $75.3B $93.1B $25.4B $24.8B --
Long-Term Debt Repaid -$74.3B -$94.4B -$33.2B -$23.8B --
Repurchase of Common Stock $1.9B $522M $4B $1.1B --
Other Financing Activities -$43M -$183M $37M -$27M --
Cash From Financing -$2.6B -$3.3B -$12.6B -$786M --
 
Beginning Cash (CF) $5.6B $4.8B $7.6B $2B --
Foreign Exchange Rate Adjustment -$463M $110M -$63M $55M --
Additions / Reductions $530M -$399M -$2.5B -$1.4B --
Ending Cash (CF) $5.7B $4.5B $5.1B $637M --
 
Levered Free Cash Flow $2.5B $3.6B $938M $1.5B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock